According to a new report by Polaris Market Research, the global Peripheral Artery Disease market was valued at USD 5.49 Billion in 2025 and is projected to reach USD 10.53 Billion by 2034, expanding at a CAGR of 7.50% over the forecast period. Growth is underpinned by the rising prevalence of diabetes and hypertension, an aging global population, and accelerating adoption of minimally invasive endovascular technologies such as drug-coated balloons and bioresorbable stents.

What Is Driving Peripheral Artery Disease Market Growth?

The steady rise in diabetes and hypertension cases is fueling the growing burden of peripheral artery disease (PAD). According to the International Diabetes Federation, 589 million adults aged 20–79 are affected by diabetes, a figure projected to reach 853 million by 2050, and both conditions are closely linked to the vascular damage that narrows peripheral arteries.

Older adults face a naturally higher risk of PAD due to cumulative vascular wear; per the US National Health and Nutrition Examination Survey, 70% of adults aged 65 and above are affected by hypertension. This demographic shift, combined with rising patient and clinician preference for minimally invasive, catheter-based therapies, is sustaining demand for interventional PAD care.

Key Trends Shaping the Peripheral Artery Disease Industry

Next-Generation Vascular Stents and Drug Delivery Devices

Vendors are emphasizing stents with enhanced radial strength and flexibility for use in twisted or calcified peripheral arteries, alongside advances in localized drug-delivery technology that expand the application of drug-coated balloons and drug-eluting stents across a wider range of lesions.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/peripheral-artery-disease-market

AI-Powered Vascular Imaging and Diagnosis

AI-assisted vascular imaging is simplifying lesion assessment and procedural planning, while machine-learning-based image analysis tools are facilitating earlier and more accurate identification of arterial narrowing within diagnostic workflows.

Digital Vascular Monitoring and Personalized Treatment

Connected remote patient monitoring platforms are supporting longer-term post-treatment surveillance and adherence tracking, while treatment decisions are increasingly shaped by individual patient risk factors and lesion-specific characteristics, reflecting a broader shift toward personalized PAD care.

Market Segmentation: Breaking Down the Peripheral Artery Disease Market

Polaris segments the peripheral artery disease market by treatment type, distribution channel, end user, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Treatment Type

The device segment accounted for approximately 62% of revenue in 2025, driven by wider adoption of stents, angioplasty balloons, and atherectomy devices for minimally invasive procedures. The drugs segment is also expanding as heightened awareness of early-stage PAD increases prescriptions of antiplatelet agents, statins, and antihypertensive medications.

By Distribution Channel

The hospital pharmacy segment led with 54.3% of revenue share in 2025, reflecting high patient inflow for complex PAD interventions such as angioplasty and bypass surgery. The retail pharmacy segment is projected to see significant growth as early-stage diagnosis and at-home chronic disease management increase.

By End User

The hospital segment accounted for the largest revenue share in 2025, given rising rates of inpatient PAD treatment such as revascularization and critical limb ischemia management. Ambulatory surgical centers are projected to post the fastest CAGR over the forecast period, driven by demand for cost-effective, same-day minimally invasive procedures.

Regional Outlook: Where Is the Peripheral Artery Disease Market Growing Fastest?

North America dominated the market with 42.7% revenue share in 2025, supported by early access to screening programs and widespread patient awareness; within the region, the U.S. accounted for 78.4% of North American revenue in 2025, driven by high incidence of comorbidities.

Asia Pacific is expected to record a significant CAGR of 8.9% from 2026 to 2034, driven by rapidly expanding healthcare systems, rising disposable income, and growing government health initiatives, with China accounting for a significant share of the regional market in 2025.

Competitive Landscape: Leading Peripheral Artery Disease Companies

Key players profiled in the report include Abbott, Boston Scientific Corporation, Medtronic, Johnson & Johnson, and Koninklijke Philips N.V., among others, who are focusing on mergers, acquisitions, and strategic alliances to broaden their vascular device portfolios and reinforce regional market positions.

Recent developments include Stryker's April 2026 definitive agreement to acquire Amplitude Vascular Systems, Inc. to add next-generation intravascular lithotripsy technology for calcified peripheral arterial disease to its portfolio, and Shockwave Medical's September 2024 U.S. launch of the Shockwave E8 Peripheral Intravascular Lithotripsy Catheter for calcified femoro-popliteal and below-the-knee lesions.

Why It Matters for Buyers Evaluating Peripheral Artery Disease Market Entry

For stakeholders researching the peripheral artery disease market, this report benchmarks market share, segment-level pricing, and forecast data — by treatment type, distribution channel, end user, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking ambulatory surgical centers as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Arachidonic Acid Market

Terminal Block Market

Behavioral Biometrics Market

Important Aspects of Lithium-ion Battery Recycling

Terminal Block Market

Energy Efficient Motor Market

Microgrid Market

Industrial Lubricants Market

South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market